# OnCo record outback (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/outback/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "outback", "NCT01414608" ;
  schema:name "OUTBACK / ANZGOG 0902 / GOG-0274"@en ;
  schema:description "Giving extra chemotherapy after chemoradiation added side effects and no survival benefit, so timing matters: chemotherapy helps before radiation (INTERLACE), not after."@en ;
  schema:url <https://onco.cc/trials/outback/> ;
  schema:dateModified "2026-09-07"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT01414608>, <https://www.thelancet.com/journals/lanonc/article/PIIS1470-2045(23)00147-X/fulltext> ;
  onco:status "negative" ;
  onco:tag "failure", "lesson:timing" ;
  onco:phase "3" ;
  schema:startDate "2012-01-09" ;
  onco:cancers <https://onco.cc/cancers/cervical/>, <https://onco.cc/cancers/locally-advanced-cervical-cancer/> ;
  onco:technologies <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/carboplatin/>, <https://onco.cc/drugs/paclitaxel/> ;
  onco:companies <https://onco.cc/companies/nrg-oncology/>, <https://onco.cc/companies/gog-foundation/> ;
  onco:people <https://onco.cc/people/linda-mileshkin/> .